[Conservative treatment of upper urinary tract tumors].
The histological appearance and the clinical behaviour of upper urinary tract urothelial tumours are almost identical to those of the bladder. Superficial papillary tumours rarely progress and turn to invasive disease despite a high frequency of recurrence. Technical developments in the endourology field have allowed full endoscopic access to upper tract tumours. Endoscopic resection or ablation of the tumour can be undertaken safely and effectively through ureteroscopy or percutaneous nephroscopy with low risk of extra-renal tumour seeding. For superficial (Ta, T1), low grade (I, II) tumours, a conservative approach can be selected without compromising survival and prognosis. For muscle invasive > T2 or high grade (III) tumours, nephroureterectomy remains the treatment of choice. Intracavitary BCG used after percutaneous resection reduces the risk of recurrence of upper tract urothelial tumours regardless of the grade. Finally, the world literature and our personal experience have shown that the tumour grade and stage are the two independent factors that affect survival of patients with upper urinary tract tumours.
Jabbour
M E
ME
Hôpital Saint-George, Université de Balamand, B.P 166 378, Achrafieh, Beyrouth 1100 2807, Liban.
Smith
A D
AD
D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000601:surgery; D003663:Decision Trees; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery; D008875:Middle Aged; D009367:Neoplasm Staging; D009392:Nephrectomy; D014513:Ureter / Q000601:surgery; D014516:Ureteral Neoplasms / Q000601:surgery; D018666:Ureteroscopy; D014571:Urologic Neoplasms / Q000473:pathology / Q000601:surgery*